Shuichi Ohkubo
10PUBLICATIONS
40CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Mar 26, 2026
LSD1 inhibitor, TAS1440, disrupts INSM1-LSD1 complex activating tumor-suppressive pathways via transcriptional reprogramming in neuroendocrine SCLC.Takumitsu Machida, Yingbo Gong, Sayaka Tsukioka
|Apr 01, 2025
Pimitespib, an HSP90 Inhibitor, Enhances the Efficacy of PARP Inhibitors in PARP Inhibitor-Insensitive Breast Cancer Cells.Hiromi Muraoka, Hiromi Kazuno, Akihiro Hashimoto
|Nov 27, 2024
The HSP90 Inhibitor Pimitespib Targets Regulatory T Cells in the Tumor Microenvironment.Ayaka Tsuge, Sho Watanabe, Akihito Kawazoe
|Dec 05, 2023
Pimitespib for the treatment of advanced gastrointestinal stromal tumors and other tumors.Toshihiko Doi, Noboru Yamamoto, Shuichi Ohkubo
|Oct 31, 2023
TAS0612, a Novel RSK, AKT, and S6K Inhibitor, Exhibits Antitumor Effects in Preclinical Tumor Models.Koji Ichikawa, Satoshi Ito, Emi Kato
|Jan 09, 2021
TAS4464, a NEDD8-activating enzyme inhibitor, activates both intrinsic and extrinsic apoptotic pathways via c-Myc-mediated regulation in acute myeloid leukemia.Hiroaki Ochiiwa, Guzhanuer Ailiken, Masataka Yokoyama
Pageof 2
Frequent Collaborators
3 joint publications
Hiromi Muraoka
2 joint publications
Tomoaki Tanaka
2 joint publications
Takumitsu Machida
2 joint publications
Toshihiko Doi
1 joint publications
Hiroki Irie
1 joint publications
Hiroaki Ochiiwa
1 joint publications
Koji Ichikawa
1 joint publications
Satoshi Ito
1 joint publications
Emi Kato
1 joint publications
Naomi Abe
